|
Birge Bargmann has served as our President Chief Executive Officer and Chief Financial Officer since November 2005 and a Director of the Company since December 2000. In November 2005 she was appointed CEO and CFO of the Company and its subsidiary. Ms. Bargmann was a member of the Supervisory Board of Proteo Biotech AG from 2002 to 2005. Since 1989 Ms. Bargmann has worked as a medical technique assistant engaged in the Elafin project at the dermatological clinic of the University of Kiel. She co-developed and carried out procedures to detect and to purify Elafin.
| 